Cariprazine Recruiting Phase 3 Trials for Schizophrenia Treatment

RecruitingTreatment3 IdentifierTitleDrugs
NCT03593213Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Patients With Schizophrenia
NCT03817502Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia